FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alexander Miller

Research Profile

Disorders

Chemicals & Drugs

Activities & Behaviors

Schizophrenic Psychology

Concepts & Ideas

Geographic Areas

Objects

Community Mental Health Centers

Occupations

Evidence-Based Medicine

Co-author Network

Publications

TOP 3
Natalie J Maples; Laurel Anne Copeland; Albana Dassori; Xueying Li; Troy A Moore; Dawn I Velligan; John E Zeber; Alexander Miller
Can medication management coordinators help improve continuity of care after psychiatric hospitalization?
Jodi Gonzalez; Linda Lopez; Gary R Bond; Dharma E Cortés; Tamara Reeves; Dawn I Velligan; Rob Whitley; Alexander Miller
Community mental health agency views of research.
Miranda Chakos; Ira D Glick; Mark B Hammer; Alexander Miller; Javendra K Patel; Robert Rosenheck; Andre Tapp; Del Miller
Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alexander Miller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Natalie J Maples; Laurel Anne Copeland; Albana Dassori; Xueying Li; Troy A Moore; Dawn I Velligan; John E Zeber; Alexander Miller
Can medication management coordinators help improve continuity of care after psychiatric hospitalization?
Psychiatric services (Washington, D.C.) 2012;63(6):554-60.
2012: Jodi Gonzalez; Linda Lopez; Gary R Bond; Dharma E Cortés; Tamara Reeves; Dawn I Velligan; Rob Whitley; Alexander Miller
Community mental health agency views of research.
Community mental health journal 2012;48(2):223-31.
2011: Miranda Chakos; Ira D Glick; Mark B Hammer; Alexander Miller; Javendra K Patel; Robert Rosenheck; Andre Tapp; Del Miller
Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.
Clinical schizophrenia & related psychoses 2011;5(3):124-34.
2011: Dawn I Velligan; Linda Lopez; Desirée A Castillo; Bren Manaugh; A Camis Milam; Alexander Miller
Interrater reliability of using brief standardized outcome measures in a community mental health setting.
Psychiatric services (Washington, D.C.) 2011;62(5):558-60.
2011: Alexander Miller
Implementing treatment guidelines.
Clinical schizophrenia & related psychoses 2011;5(1):15-6.
2011: John E Zeber; Alexander Miller; Laurel A Copeland; John F McCarthy; Kara Zivin; Marcia Valenstein; Devra Greenwald; Amy M Kilbourne
Medication adherence, ethnicity, and the influence of multiple psychosocial and financial barriers.
Administration and policy in mental health 2011;38(2):86-95.
2011: Olga C Chaves; Lauren E Lombardo; Carrie E Bearden; Mary D Woolsey; David M Martinez; Jennifer A Barrett; Alexander Miller; Dawn I Velligan; David C Glahn
Association of clinical symptoms and neurocognitive performance in bipolar disorder: a longitudinal study.
Bipolar disorders 2011;13(1):118-23.
2011: Albana M Dassori; Laurel A Copeland; John E Zeber; Alexander Miller
Factors in second-generation antipsychotic switching patterns in a national sample of older veterans with schizophrenia.
Psychiatric services (Washington, D.C.) 2011;62(1):47-53.
2010: Laurel A Copeland; Michael L Parchman; John E Zeber; Valerie Lawrence; John R Downs; Alexander Miller
Prediabetes assessment and follow-up in older veterans with schizophrenia.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2010;18(10):887-96.
2010: Alexander Miller; Hoa Vo; Liang Huo; Catherine Roca; Peter J Schmidt; David R Rubinow
Estrogen receptor alpha (ESR-1) associations with psychological traits in women with PMDD and controls.
Journal of psychiatric research 2010;44(12):788-94.
2010: Jodi Gonzalez; Dawn I Velligan; L Lopez; Jim Mintz; G R Bond; Alexander Miller
Academic-community partnership: an orientation for employees of a community mental health agency to its research program.
Education for health (Abingdon, England) 2010;23(2):386.
2010: Alexander Miller; Albana Dassori; Linda Lopez; Desiree A Castillo; Jodi Gonzalez; Charles Boone; Camis Milam; Gary R Bond; Dawn I Velligan
Public-academic partnerships: tools for mental health agencies to evaluate research protocols.
Psychiatric services (Washington, D.C.) 2010;61(5):446-8.
2010: David Rubinow; Alexander Miller; Katya B Rubinow
DSM-V: an opportunity to embrace the future of psychiatric diagnosis.
Archives of women's mental health 2010;13(1):3-4.
2009: Dawn I Velligan; Pamela Diamond; Janet Mueller; Xueying Li; Natalie Maples; Mei Wang; Alexander Miller
The short-term impact of generic versus individualized environmental supports on functional outcomes and target behaviors in schizophrenia.
Psychiatry research 2009;168(2):94-101.
2009: Patricia B Howard; Peggy El-Mallakh; Alexander Miller; Mary Kay Rayens; Gary R Bond; Karen Henderson; Andrew T Cooley
Prescriber fidelity to a medication management evidence-based practice in the treatment of schizophrenia.
Psychiatric services (Washington, D.C.) 2009;60(7):929-35.
2009: Amanda C Taylor; Gary R Bond; Jack Tsai; Patricia B Howard; Peggy El-Mallakh; Molly Finnerty; Edith Kealey; Britt Myrhol; Karin Kalk; Neal Adams; Alexander Miller
Scales to evaluate quality of medication management: development and psychometric properties.
Administration and policy in mental health 2009;36(4):247-54.
2009: Alexander Miller; Scott C Sherman
Crack eye.
The Journal of emergency medicine 2009;37(1):75-6.
2009: Laurel A Copeland; Alexander Miller; Deborah E Welsh; John F McCarthy; John E Zeber; Amy M Kilbourne
Clinical and demographic factors associated with homelessness and incarceration among VA patients with bipolar disorder.
American journal of public health 2009;99(5):871-7.
2009: Laurel A Copeland; John E Zeber; Chen-Pin Wang; Michael L Parchman; Valerie Lawrence; Marcia Valenstein; Alexander Miller
Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization.
BMC health services research 2009;9():127.
2009: Thomas Stroup; Jeffrey A Lieberman; Joseph P McEvoy; Sonia M Davis; Marvin Swartz; Richard S E Keefe; Alexander Miller; Robert A Rosenheck; John K Hsiao
Results of phase 3 of the CATIE schizophrenia trial.
Schizophrenia research 2009;107(1):1-12.
2008: Alexander Miller; Linda Lopez; Jodi Gonzalez; Albana Dassori; Gary Bond; Dawn I Velligan
Public-academic partnerships: research in community mental health settings: a practicum experience for researchers.
Psychiatric services (Washington, D.C.) 2008;59(11):1246-8.
2008: Dawn I Velligan; Pamela Diamond; Natalie Maples; Jim Mintz; Xueying Li; David C Glahn; Alexander Miller
Comparing the efficacy of interventions that use environmental supports to improve outcomes in patients with schizophrenia.
Schizophrenia research 2008;102(1-3):312-9.
2008: Dawn I Velligan; Pamela Diamond; Jim Mintz; Natalie Maples; Xueying Li; John E Zeber; Larry Ereshefsky; Yui-Wing Lam; Desiree Castillo; Alexander Miller
The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia.
Schizophrenia bulletin 2008;34(3):483-93.
2008: Donald C Goff; J Steven Lamberti; Andrew C Leon; Michael F Green; Alexander Miller; Jayendra Patel; Theo C Manschreck; Oliver Freudenreich; Steven A Johnson
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(3):465-72.
2008: William D Frey; Susan T Azrin; Howard H Goldman; Susan Kalasunas; David S Salkever; Alexander Miller; Gary R Bond; Robert E Drake
The mental health treatment study.
Psychiatric rehabilitation journal 2008;31(4):306-12.
2007: Troy A Moore; Robert W Buchanan; Peter F Buckley; John A Chiles; Robert R Conley; M Lynn Crismon; Susan M Essock; Molly Finnerty; Stephen R Marder; Joseph P McEvoy; Delbert Robinson; Nina R Schooler; Steven P Shon; Thomas Stroup; Del D Miller; Alexander Miller
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.
The Journal of clinical psychiatry 2007;68(11):1751-62.
2007: Peter F Buckley; Christoph Correll; Alexander Miller
First-episode psychosis: a window of opportunity for best practices.
CNS spectrums 2007;12(9 Suppl 15):1-12; discussion 13-4; quiz 15-6.
2007: Dawn I Velligan; Mei Wang; Pamela Diamond; David C Glahn; Desiree Castillo; Scott Bendle; Yui-Wing Lam; Larry Ereshefsky; Alexander Miller
Relationships among subjective and objective measures of adherence to oral antipsychotic medications.
Psychiatric services (Washington, D.C.) 2007;58(9):1187-92.
2007: Troy A Moore; Nancy H Covell; Susan M Essock; Alexander Miller
Real-world antipsychotic treatment practices.
The Psychiatric clinics of North America 2007;30(3):401-16.
2007: Lei Wang; Malini Hosakere; Joshua C L Trein; Alexander Miller; J Tilak Ratnanather; Deanna M Barch; Paul Thompson; Shen-Hsing Annabel Chen; Mokhtar H Gado; Michael I Miller; John G Csernansky
Abnormalities of cingulate gyrus neuroanatomy in schizophrenia.
Schizophrenia research 2007;93(1-3):66-78.
2007: Dawn I Velligan; Pamela Diamond; David C Glahn; Janice L Ritch; Natalie Maples; Desiree Castillo; Alexander Miller
The reliability and validity of the Test of Adaptive Behavior in Schizophrenia (TABS).
Psychiatry research 2007;151(1-2):55-66.
2007: Thomas Stroup; Jeffrey A Lieberman; Joseph P McEvoy; Marvin Swartz; Sonia M Davis; George Capuano; Robert A Rosenheck; Richard S E Keefe; Alexander Miller; Irving Belz; John K Hsiao
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
The American journal of psychiatry 2007;164(3):415-27.
2007: Peter Weiden; Alexander Miller; Tim J Lambert; Peter F Buckley
The art and science of switching antipsychotic medications, part 2.
The Journal of clinical psychiatry 2007;68(1):e02.
2006: Dawn I Velligan; Yui-Wing Lam; David C Glahn; Jennifer A Barrett; Natalie Maples; Larry Ereshefsky; Alexander Miller
Defining and assessing adherence to oral antipsychotics: a review of the literature.
Schizophrenia bulletin 2006;32(4):724-42.
2006: Marcia G Toprac; Ellen B Dennehy; Thomas J Carmody; M Lynn Crismon; Alexander Miller; Madhukar H Trivedi; Trisha Suppes; john rush
Implementation of the Texas Medication Algorithm Project patient and family education program.
The Journal of clinical psychiatry 2006;67(9):1362-72.
2006: Miranda Chakos; Ira D Glick; Alexander Miller; Mark B Hamner; Del D Miller; Jayendra K Patel; Andre Tapp; Richard S E Keefe; Robert A Rosenheck
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial.
Psychiatric services (Washington, D.C.) 2006;57(8):1094-101.
2006: Roderick K Mahurin; Dawn I Velligan; Bonnie Hazleton; J Mark Davis; Stacey Eckert; Alexander Miller
Trail making test errors and executive function in schizophrenia and depression.
The Clinical neuropsychologist 2006;20(2):271-88.
2006: T Michael Kashner; A John Rush; M Lynn Crismon; Marcia G Toprac; Thomas J Carmody; Alexander Miller; Madhukar H Trivedi; Annie Wicker; Trisha Suppes
An empirical analysis of cost outcomes of the Texas Medication Algorithm Project.
Psychiatric services (Washington, D.C.) 2006;57(5):648-59.
2006: Laurel A Copeland; John E Zeber; Robert A Rosenheck; Alexander Miller
Unforeseen inpatient mortality among veterans with schizophrenia.
Medical care 2006;44(2):110-6.
2005: Ellen B Dennehy; Trisha Suppes; john rush; Alexander Miller; Madhukar H Trivedi; M Lynn Crismon; Thomas J Carmody; T Michael Kashner
Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project.
Psychological medicine 2005;35(12):1695-706.
2005: Nick C Patel; M Lynn Crismon; Alexander Miller; Michael T Johnsrud
Drug adherence: effects of decreased visit frequency on adherence to clozapine therapy.
Pharmacotherapy 2005;25(9):1242-7.
2005: Dawn I Velligan; Thomas J Prihoda; Ellen B Dennehy; Melanie Biggs; Kathy Shores-Wilson; M Lynn Crismon; A John Rush; Alexander Miller; Trisha Suppes; Madhukar Trivedi; T Michael Kashner; Bradley P Witte; Marcia G Toprac; Thomas J Carmody; John A Chiles; Steven P Shon
Brief psychiatric rating scale expanded version: How do new items affect factor structure?
Psychiatry research 2005;135(3):217-28.
2004: Dawn I Velligan; Margaret DiCocco; C Christine Bow-Thomas; Christopher Cadle; David C Glahn; Alexander Miller; Melanie Biggs; Kathy Shores-Wilson; Christine A McKenzie; M Lynn Crismon
A brief cognitive assessment for use with schizophrenia patients in community clinics.
Schizophrenia research 2004;71(2-3):273-83.
2004: Alexander Miller
Combination treatments for schizophrenia.
CNS spectrums 2004;9(9 Suppl 9):19-23.
2004: Stephen R Marder; Susan M Essock; Alexander Miller; Robert W Buchanan; Daniel E Casey; John M Davis; John M Kane; Jeffrey A Lieberman; Nina R Schooler; Nancy H Covell; Scott Stroup; Ellen M Weissman; Donna A Wirshing; Catherine S Hall; Leonard Pogach; Xavier Pi-Sunyer; J Thomas Bigger; Alan Friedman; David Kleinberg; Steven J Yevich; Bonnie Davis; Steven P Shon
Physical health monitoring of patients with schizophrenia.
The American journal of psychiatry 2004;161(8):1334-49.
2004: Madhukar H Trivedi; A John Rush; M Lynn Crismon; T Michael Kashner; Marcia G Toprac; Thomas J Carmody; Tracie Key; Melanie Biggs; Kathy Shores-Wilson; Bradley P Witte; Trisha Suppes; Alexander Miller; Kenneth Z Altshuler; Steven P Shon
Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.
Archives of general psychiatry 2004;61(7):669-80.
2004: Alexander Miller; Catherine S Hall; Robert W Buchanan; Peter F Buckley; John A Chiles; Robert R Conley; M Lynn Crismon; Larry Ereshefsky; Susan M Essock; Molly Finnerty; Stephen R Marder; Del D Miller; Joseph P McEvoy; A John Rush; Sy A Saeed; Nina R Schooler; Steven P Shon; Scott Stroup; Bernardo Tarin-Godoy
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.
The Journal of clinical psychiatry 2004;65(4):500-8.
2004: Anthony Lehman; Jeffrey A Lieberman; Lisa Dixon; Thomas H McGlashan; Alexander Miller; Diana O Perkins; Julie Kreyenbuhl
Practice guideline for the treatment of patients with schizophrenia, second edition.
The American journal of psychiatry 2004;161(2 Suppl):1-56.
2004: Alexander Miller; M Lynn Crismon; A John Rush; John A Chiles; T Michael Kashner; Marcia G Toprac; Thomas J Carmody; Melanie Biggs; Kathy Shores-Wilson; Judith Chiles; Brad Witte; C Christine Bow-Thomas; Dawn I Velligan; Madhukar Trivedi; Trisha Suppes; Steven P Shon
The Texas medication algorithm project: clinical results for schizophrenia.
Schizophrenia bulletin 2004;30(3):627-47.
2004: Alexander Miller
PORT treatment recommendations.
Schizophrenia bulletin 2004;30(3):601-4.
2003: Naakesh Dewan; Douglas Conley; Dale Svendsen; Steven P Shon; John R Staup; Alexander Miller; M Lynn Crismon; A John Rush; Madhukar Trivedi; Tracy Skale; Paul E Keck; Stephen M Strawkowski
A quality improvement process for implementing the Texas algorithm for schizophrenia in Ohio.
Psychiatric services (Washington, D.C.) 2003;54(12):1646-9.
2003: Dawn I Velligan; Thomas J Prihoda; Dawen Sui; Janice L Ritch; Natalie Maples; Alexander Miller
The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings.
The Journal of clinical psychiatry 2003;64(5):524-31.
2003: Dawn I Velligan; Yui-Wing Lam; Larry Ereshefsky; Alexander Miller
Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications.
Psychiatric services (Washington, D.C.) 2003;54(5):665-7.
2003: Alexander Miller
Review: there is no strong evidence to support antipsychotic combination therapy in schizophrenia.
Evidence-based mental health 2003;6(2):53.
2003: M Lynn Crismon; Anthony DeLeon; Alexander Miller
Aripiprazole: does partial dopaminergic agonism translate into clinical benefits?
The Annals of pharmacotherapy 2003;37(5):738-40.
2003: Trisha Suppes; A John Rush; Ellen B Dennehy; M Lynn Crismon; T Michael Kashner; Marcia G Toprac; Thomas J Carmody; E Sherwood Brown; Melanie Biggs; Kathy Shores-Wilson; Bradley P Witte; Madhukar H Trivedi; Alexander Miller; Kenneth Z Altshuler; Steven P Shon
Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania.
The Journal of clinical psychiatry 2003;64(4):370-82.
2003: A John Rush; M Lynn Crismon; T Michael Kashner; Marcia G Toprac; Thomas J Carmody; Madhukar H Trivedi; Trisha Suppes; Alexander Miller; Melanie Biggs; Kathy Shores-Wilson; Bradley P Witte; Steven P Shon; William V Rago; Kenneth Z Altshuler
Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design.
The Journal of clinical psychiatry 2003;64(4):357-69.
2003: T Michael Kashner; Thomas J Carmody; Trisha Suppes; john rush; M Lynn Crismon; Alexander Miller; Marcia G Toprac; Madhukar Trivedi
Catching up on health outcomes: the Texas Medication Algorithm Project.
Health services research 2003;38(1 Pt 1):311-31.
2002: Dawn I Velligan; John W Newcomer; Joseph Pultz; John G Csernansky; Anne Hoff; Roderick K Mahurin; Alexander Miller
Does cognitive function improve with quetiapine in comparison to haloperidol?
Schizophrenia research 2002;53(3):239-48.
2002: Kathy Shores-Wilson; Melanie Biggs; Alexander Miller; Thomas J Carmody; John A Chiles; A John Rush; M Lynn Crismon; Marcia G Toprac; Bradley P Witte; Joe C Webster
Itemized clinician ratings versus global ratings of symptom severity in patients with schizophrenia.
International journal of methods in psychiatric research 2002;11(1):45-53.
2002: Stephen R Marder; Susan M Essock; Alexander Miller; Robert W Buchanan; John M Davis; John M Kane; Jeffrey Lieberman; Nina R Schooler
The Mount Sinai conference on the pharmacotherapy of schizophrenia.
Schizophrenia bulletin 2002;28(1):5-16.
2002: Alexander Miller; Catherine S Craig
Combination antipsychotics: pros, cons, and questions.
Schizophrenia bulletin 2002;28(1):105-9.
2001: Thomas A Mellman; Alexander Miller; Ellen M Weissman; M L Crismon; Susan M Essock; S R Marder
Evidence-based pharmacologic treatment for people with severe mental illness: a focus on guidelines and algorithms.
Psychiatric services (Washington, D.C.) 2001;52(5):619-25.
2001: SG Dott; Peter Weiden; P Hopwood; A G Awad; J S Hellewell; J Knesevich; L Kopala; Alexander Miller; Carl Salzman
An innovative approach to clinical communication in schizophrenia: the approaches to schizophrenia communication checklists.
CNS spectrums 2001;6(4):333-8.
2001: Peter Weiden; Alexander Miller
Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications.
Journal of psychiatric practice 2001;7(1):41-7.
2001: Peter F Buckley; Alexander Miller; J Olsen; D Garver; D D Miller; J Csernansky
When symptoms persist: clozapine augmentation strategies.
Schizophrenia bulletin 2001;27(4):615-28.
2000: Robert E Drake; Kim T Mueser; William C Torrey; Alexander Miller; Anthony Lehman; Gary R Bond; Howard H Goldman; H Stephen Leff
Evidence-based treatment of schizophrenia.
Current psychiatry reports 2000;2(5):393-7.
2000: Dawn I Velligan; C Christine Bow-Thomas; Roderick K Mahurin; Alexander Miller; L C Halgunseth
Do specific neurocognitive deficits predict specific domains of community function in schizophrenia?
The Journal of nervous and mental disease 2000;188(8):518-24.
2000: Dawn I Velligan; C Christine Bow-Thomas; C Huntzinger; Janice L Ritch; N Ledbetter; Thomas J Prihoda; Alexander Miller
Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia.
The American journal of psychiatry 2000;157(8):1317-23.
1999: Alexander Miller; John A Chiles; J K Chiles; M Lynn Crismon; A John Rush; Steven P Shon
The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms.
The Journal of clinical psychiatry 1999;60(10):649-57.
1999: Peter F Buckley; Alexander Miller; John A Chiles; Martha Sajatovic
Implementing effectiveness research and improving care for schizophrenia in real-world settings.
The American journal of managed care 1999;5 Spec No():SP47-56.
1999: C Christine Bow-Thomas; Dawn I Velligan; Alexander Miller; J Olsen
Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization.
Psychiatry research 1999;86(2):131-42.
1999: A John Rush; William V Rago; M Lynn Crismon; Marcia G Toprac; Steven P Shon; Trisha Suppes; Alexander Miller; Madhukar H Trivedi; Alan C Swann; Melanie Biggs; Kathy Shores-Wilson; T Michael Kashner; T Pigott; John A Chiles; DA Gilbert; Kenneth Z Altshuler
Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project.
The Journal of clinical psychiatry 1999;60(5):284-91.
1999: Dawn I Velligan; Alexander Miller
Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment.
The Journal of clinical psychiatry 1999;60 Suppl 23():25-8.
1999: Steven P Shon; M Lynn Crismon; Marcia G Toprac; M Trivedi; Alexander Miller; Trisha Suppes; A John Rush
Mental health care from the public perspective: the Texas Medication Algorithm Project.
The Journal of clinical psychiatry 1999;60 Suppl 3():16-20; discussion 21.
1999: John A Chiles; Alexander Miller; M Lynn Crismon; A John Rush; A S Krasnoff; S S Shon
The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm.
Psychiatric services (Washington, D.C.) 1999;50(1):69-74.
1998: Dawn I Velligan; C Christine Bow-Thomas; Roderick K Mahurin; Alexander Miller; Albana Dassori; F Erdely
Concurrent and predictive validity of the Allen Cognitive Levels Assessment.
Psychiatry research 1998;80(3):287-98.
1998: Roderick K Mahurin; Dawn I Velligan; Alexander Miller
Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis.
Psychiatry research 1998;79(2):139-49.
1998: Albana Dassori; Alexander Miller; Dawn I Velligan; D Saldana; P Diamond; Roderick K Mahurin
Ethnicity and negative symptoms in patients with schizophrenia.
Cultural diversity and mental health 1998;4(1):65-9.
1997: Dawn I Velligan; Roderick K Mahurin; P L Diamond; Bonnie Hazleton; S L Eckert; Alexander Miller
The functional significance of symptomatology and cognitive function in schizophrenia.
Schizophrenia research 1997;25(1):21-31.
1997: Dawn I Velligan; Roderick K Mahurin; S L Eckert; Bonnie Hazleton; Alexander Miller
Relationship between specific types of communication deviance and attentional performance in patients with schizophrenia.
Psychiatry research 1997;70(1):9-20.
1997: Alexander Miller; Larry Ereshefsky
Schizophrenia: how should we look at it?
Journal of psychopharmacology (Oxford, England) 1997;11(1):21-3; discussion 28.
1997: J W Maas; Charles L Bowden; Alexander Miller; Martin A Javors; L G Funderburg; N Berman; Susan Weintraub
Schizophrenia, psychosis, and cerebral spinal fluid homovanillic acid concentrations.
Schizophrenia bulletin 1997;23(1):147-54.
1996: Dawn I Velligan; Alexander Miller; S L Eckert; L G Funderburg; J E True; Roderick K Mahurin; P Diamond; B C Hazelton
The relationship between parental communication deviance and relapse in schizophrenic patients in the 1-year period after hospital discharge. A pilot study.
The Journal of nervous and mental disease 1996;184(8):490-6.
1996: S L Eckert; P M Diamond; Alexander Miller; Dawn I Velligan; L G Funderburg; J E True
A comparison of instrument sensitivity to negative symptom change.
Psychiatry research 1996;63(1):67-75.
1995: J W Maas; Alexander Miller; Janet L Tekell; L Funderburg; J Arturo Silva; J True; Dawn I Velligan; N Berman; Charles L Bowden
Clonidine plus haloperidol in the treatment of schizophrenia/psychosis.
Journal of clinical psychopharmacology 1995;15(5):361-4.
1995: Stephen K Brannan; Alexander Miller; D J Jones; Gerald L Kramer; Frederick Petty
Beta-adrenergic receptor changes in learned helplessness may depend on stress and test parameters.
Pharmacology, biochemistry, and behavior 1995;51(2-3):553-6.
1995: Alexander Miller; Roderick K Mahurin; Dawn I Velligan; J W Maas
Negative symptoms of schizophrenia: where do we go from here?
Biological psychiatry 1995;37(10):691-3.
1995: Dawn I Velligan; L G Funderburg; S L Giesecke; Alexander Miller
Longitudinal analysis of communication deviance in the families of schizophrenic patients.
Psychiatry 1995;58(1):6-19.
1995: A M Dassori; Alexander Miller; D Saldana
Schizophrenia among Hispanics: epidemiology, phenomenology, course, and outcome.
Schizophrenia bulletin 1995;21(2):303-12.
1994: L G Funderburg; J E Vertrees; J E True; Alexander Miller
Seizure following addition of erythromycin to clozapine treatment.
The American journal of psychiatry 1994;151(12):1840-1.
1994: C Lyster; Alexander Miller; D Seidel; J Kavanagh
Polydipsia and clozapine.
Hospital & community psychiatry 1994;45(6):610-1.
1993: Donald Royall; Roderick K Mahurin; J E True; B Anderson; I P Brock; L Freeburger; Alexander Miller
Executive impairment among the functionally dependent: comparisons between schizophrenic and elderly subjects.
The American journal of psychiatry 1993;150(12):1813-9.
1993: Alexander Miller; J W Maas; S Contreras; E Seleshi; J E True; Charles L Bowden; J Castiglioni
Acute effects of neuroleptics on unmedicated schizophrenic patients and controls.
Biological psychiatry 1993;34(3):178-87.
1993: J W Maas; S A Contreras; Alexander Miller; N Berman; Charles L Bowden; Martin A Javors; E Seleshi; Susan Weintraub
Studies of catecholamine metabolism in schizophrenia/psychosis--I.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;8(2):97-109.
1993: J W Maas; S A Contreras; Alexander Miller; N Berman; Charles L Bowden; Martin A Javors; E Seleshi; Susan Weintraub
Studies of catecholamine metabolism in schizophrenia/psychosis--II.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;8(2):111-6.
1990: Alexander Miller; John P Hatch; T J Prihoda
Dichloroacetate increases glucose use and decreases lactate in developing rat brain.
Metabolic brain disease 1990;5(4):195-204.
1989: Alexander Miller; R A Hawkins
Fluorodeoxyglucose rate constants in rat brain.
Neuroscience 1989;30(2):557-8.
1988: Charles L Bowden; Alexander Miller; E Seleshi
New developments in the treatment of anxiety disorders.
Texas medicine 1988;84(9):38-42.
1987: Richard A Hawkins; Alexander Miller
Deoxyglucose-6-phosphate stability in vivo and the deoxyglucose method.
Journal of neurochemistry 1987;49(6):1941-60.
1987: E Eidelberg; Alexander Miller; R J Schwartzman; G M Alexander
Measurements of regional glucose metabolism in studies of motor control.
Journal of neuroscience methods 1987;21(2-4):139-44.
1987: Alexander Miller; R W Keenan; J W Maas; R H Asch
Disposition of homovanillic acid in the primate.
Metabolic brain disease 1987;2(3):207-12.
1986: Alexander Miller; M A Medina
Cerebral metabolic effects of organophosphorus anticholinesterase compounds.
Metabolic brain disease 1986;1(2):147-56.
1986: Alexander Miller
Regional glucose and beta-hydroxybutyrate use by developing rat brain.
Metabolic brain disease 1986;1(1):53-61.
1985: Alexander Miller; Charles L Bowden; J Plewes
Lithium and impairment of renal concentrating ability.
Journal of affective disorders 1985;9(2):115-9.
1985: Alexander Miller; R A Faber; John P Hatch; H E Alexander
Factors affecting amnesia, seizure duration, and efficacy in ECT.
The American journal of psychiatry 1985;142(6):692-6.
1985: E Eidelberg; Alexander Miller
Effects of sensory deafferentation on glucose metabolism of muscles during locomotion.
Brain research 1985;327(1-2):316-8.